VANCOUVER, Sept. 17 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ:
ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company,
today announced positive preclinical data related to its Vascular Wrap(TM)
paclitaxel-eluting mesh and Lifespan(R) graft technology platform at The
Western Vascular Society 2006 Annual Meeting in La Jolla, California.